Redeye provides a short comment on Scandinavian ChemoTech announcing sales of USD390k in the second ...
Q2 report Friday, 18 July at 12:00 CET '25e-'27e adj.
Redeye comments on SSH Communications' announcement that it intends to enter a strategic partnership...
Duell lowered its guidance for FY 2025 as weakened market conditions resulted in weaker-than-expecte...
Organic growth could remain close to zero for H1 2025E y/y, but acquisitions should at least offer 6...
Redeye shares its preview of BONESUPPORT’s Q2 2025 results, due July 15.
Redeye comments on the changes in CLS’s Board of Directors.
Return gives its insights on the recently published PROPEL data.
Redeye revises its financial forecast and valuation of Polygiene following the change of lead analys...
Synthetic MR:s förseningar i lanseringen av SyMRI 3D har lett till ett svagt första kvartal 2025, me...
Investors House has sold its 2/3 stake in JV Apitare to Nordisk Renting Oy and the minority owner Ov...
Nettoomsättningen för det första kvartalet uppgick till 4,6 (3,5) miljoner kronor.
Administer announced that it intends to acquire the financial, payroll and software services busines...
Adjusting the organisation, at cost of top line and near-term earnings Expect Q2-Q3 headwinds; we cu...
Redsense växer stabilt med stigande omsättning och förbereder lansering av Clamp i Storbritannien.
